This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mohand-Said, S. Articles by Sahel, J. A. Search for Related Content PubMed PubMed Citation Articles by Mohand-Said, S. Articles by Sahel, J. A.

(Stroke. 1997;28:617-622.)
© 1997 American Heart Association, Inc.

Articles

Intravitreal Injection of Ganglioside GM1 After Ischemia Reduces Retinal Damage in Rats

Saddek Mohand-Said, MD; Michel Weber, MD; David Hicks, PhD; Henri Dreyfus, PhD; José Alain Sahel, MD

From the Laboratoire de Physiopathologie Rétinienne, INSERM CJF 92-02, Université Louis Pasteur, Strasbourg, and Clinique Ophthalmologique, Centre Hospitalo–Universitaire de Nantes (M.W., J.A.S.) (France).

Background and Purpose Gangliosides are normal components of cell membranes and contribute to structural rigidity and membrane function. They have been shown to protect against various insults in the brain. We have shown previously that GM1 administered intraperitoneally before the induction of retinal ischemia provides a protective effect. This study evaluates the protective effect of GM1 administered intravitreally after ischemia on retinal lesions.

Methods We induced retinal ischemia unilaterally in Long-Evans rats by increasing intraocular pressure to 160 mm Hg for 60 minutes. GM1 (20 µL · 10^-5 mol/L) or saline (20 µL) was injected into the vitreous 15 minutes after ischemia, and the postischemic survival time was either 8 or 15 days. The degree of retinal damage was assessed by histopathological study.

Results Retinal ischemia led to reductions in thickness and cell number, principally in the inner retinal layers (39% to 80%) and to a lesser extent in the outer retinal layers (26% to 45%). Postischemic treatment with intravitreally injected GM1 conferred significant protection against retinal ischemic damage after both 8 and 15 days of survival time. After 8 days of reperfusion, the ischemia-induced loss in overall retinal thickness was reduced by 15% and those of the inner nuclear and plexiform layers by 44% and 17%, respectively. Ischemic-induced ganglion cell and inner nuclear cell density losses were reduced by 37% and 27%, respectively. After 15 days of reperfusion, approximately the same statistically significant differences could be observed in comparison with the 15-day saline-injected group.

Conclusions GM1 protects the rat retina from pressure-induced ischemic injury when given intravitreally after the insult. The protection provided by GM1 after initiation of retinal damage could be of therapeutic interest.

Key Words: animal models • gangliosides • neuroprotection • retina • rats

This article has been cited by other articles:

				E. J. Park, M. Suh, and M. T. Clandinin Dietary Ganglioside and Long-Chain Polyunsaturated Fatty Acids Increase Ganglioside GD3 Content and Alter the Phospholipid Profile in Neonatal Rat Retina Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2571 - 2575. [Abstract] [Full Text] [PDF]

				C.-L. Schengrund and P. Kovác A simple, nonenzymatic method for desialylating polysialylated ganglio-N-tetraose series gangliosides to produce GM1 J. Lipid Res., January 1, 1999; 40(1): 160 - 163. [Abstract] [Full Text]